Maximize Safety When Using Anticoagulants in Patients With Cirrhosis
You'll see anticoagulants used more often to treat thrombosis in patients with cirrhosis.
We're used to thinking of these patients as having an increased bleeding risk...due to impaired clotting factor production and thrombocytopenia.
But don't consider them "auto-anticoagulated." Decreased protein C and other prothrombotic changes typically rebalance bleeding risk.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote